Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome

Open Access
Publisher Website
Google Scholar
Abstract
Intravenous immunoglobulin (IVIg) therapy is being increasingly used in a wide range of neurological conditions. However, treatment is expensive and side effects may be severe. A patient with Miller Fisher syndrome who developed cortical blindness as a consequence of occipital infarction precipitated by IVIg is reported on.

This publication has 0 references indexed in Scilit: